[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [BUSINESS]

2 clusters · 6 sources · 3 days · First seen · Last updated

Novartis biomedical research and manufacturing expansion

Overview

Novartis has initiated several strategic expansions in research and specialized manufacturing. In the United States, the company has broken ground on a 466,000-square-foot biomedical research center in San Diego, California. This facility is intended to integrate AI-enabled discovery capabilities for neuroscience and oncology, with plans to house approximately 1,000 employees by 2029.

In Spain, Novartis is emphasizing the importance of its radioligand plant in La Almunia de Doña Godina. As one of only five such facilities worldwide, the plant produces nuclear anti-cancer therapies, with more than 85% of its output exported to international markets.

Concurrently, the Sanitas Foundation for Medical Research and Innovation reported a 33% annual increase in clinical trials. Research efforts are currently focused on neurosciences, including gene therapy trials and precision molecules, aiming to accelerate patient access to innovative drugs.

Entities

Novartis · Basel · Spain · Sonia Gutiérrez · Todd Gloria

Timeline

  1. [HEALTH] 3 sources
    Novartis and Sanitas highlight medical innovation and clinical trial expansion

    Novartis and Sanitas emphasize the importance of clinical research and specialized manufacturing to accelerate patient access to innovative medical treatments and reduce healthcare inequities.

  2. [BUSINESS] 3 sources
    Novartis breaks ground on new biomedical research center in San Diego

    Novartis has broken ground on a new 466,000-square-foot biomedical research center in San Diego, expected to house 1,000 employees by 2029.

Sources

ariadna.elmundo.es · diarioestrategia.cl · engineering.missouri.edu · larazon.es · sustainablefish.org · urgentcareassociation.org